You are here

  • Home
  • Archive
  • Volume 9, Issue 3
  • Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score

Article metrics

Article menu

This article has a correction. Please see:

XML
Immunotherapy biomarkers
Original research
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score

 

Online download statistics by month:

Online download statistics by month: March 2021 to October 2023

AbstractFullPdf
Mar 2021535535112
Apr 2021303303103
May 202123723742
Jun 202116616647
Jul 202111311434
Aug 202113013139
Sep 202113013044
Oct 202113813836
Nov 202112011956
Dec 202110811242
Jan 20229310039
Feb 2022657134
Mar 2022909958
Apr 2022636730
May 2022787933
Jun 202210110837
Jul 2022798729
Aug 2022808318
Sep 2022676935
Oct 2022757724
Nov 2022636536
Dec 2022555523
Jan 2023363620
Feb 2023717115
Mar 2023596118
Apr 2023384125
May 2023262610
Jun 2023222210
Jul 2023414125
Aug 2023414111
Sep 2023292912
Oct 2023383814
Total329033511111